Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 20934 | 440 | 35.5 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 257 | 3 | JOURNAL OF PARENTERAL AND ENTERAL NUTRITION//ENTERAL NUTRITION//NUTRITION & DIETETICS | 44865 |
| 992 | 2 | SARCOPENIA//CANCER CACHEXIA//BODY COMPOSITION | 10472 |
| 20934 | 1 | CHEMOTHERAPY DOSING//DOSE BANDING//GRANULOCYTE MACROPHAGE PROGENITOR CELLS CFU GM | 440 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CHEMOTHERAPY DOSING | authKW | 156143 | 1% | 75% | 3 |
| 2 | DOSE BANDING | authKW | 156143 | 1% | 75% | 3 |
| 3 | GRANULOCYTE MACROPHAGE PROGENITOR CELLS CFU GM | authKW | 138795 | 0% | 100% | 2 |
| 4 | DRUG WASTE | authKW | 89222 | 1% | 43% | 3 |
| 5 | BODY SURFACE AREA | authKW | 71896 | 4% | 6% | 16 |
| 6 | ABDOMINOSURGICAL SPECTRUM OF SURGICAL INTERVENTIONS | authKW | 69398 | 0% | 100% | 1 |
| 7 | ACHONDROPLASTIC DWARFISM | authKW | 69398 | 0% | 100% | 1 |
| 8 | ADJUVANT CYCLOPHOSPHAMIDE | authKW | 69398 | 0% | 100% | 1 |
| 9 | ALTERED CLEARANCE | authKW | 69398 | 0% | 100% | 1 |
| 10 | AMOXICILLIN PENETRATION | authKW | 69398 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1980 | 40% | 0% | 175 |
| 2 | Oncology | 1230 | 28% | 0% | 125 |
| 3 | Anesthesiology | 196 | 4% | 0% | 19 |
| 4 | Pediatrics | 59 | 5% | 0% | 22 |
| 5 | Nutrition & Dietetics | 58 | 4% | 0% | 16 |
| 6 | Infectious Diseases | 55 | 4% | 0% | 18 |
| 7 | Hematology | 44 | 4% | 0% | 17 |
| 8 | Obstetrics & Gynecology | 38 | 4% | 0% | 16 |
| 9 | Nursing | 30 | 2% | 0% | 8 |
| 10 | Surgery | 19 | 6% | 0% | 26 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOQUEMISTRY | 69398 | 0% | 100% | 1 |
| 2 | CANC ST JOSEPHS HOSP MED MED | 69398 | 0% | 100% | 1 |
| 3 | COREVIH ILE DE FRANCE | 69398 | 0% | 100% | 1 |
| 4 | CUB ERASME HOSP | 69398 | 0% | 100% | 1 |
| 5 | DICON | 69398 | 0% | 100% | 1 |
| 6 | DRUG PROD CONTROL PHARMACEUT SCI | 69398 | 0% | 100% | 1 |
| 7 | EA CLAUDIUS REGAUD 4553 | 69398 | 0% | 100% | 1 |
| 8 | GCIG SECRETARIAT | 69398 | 0% | 100% | 1 |
| 9 | GEN MEDICINE | 69398 | 0% | 100% | 1 |
| 10 | KRANKENHAUS NATRUPER HOLZ | 69398 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CLINICAL PHARMACOKINETICS | 6615 | 3% | 1% | 15 |
| 2 | BARIATRIC NURSING AND SURGICAL PATIENT CARE | 3850 | 1% | 2% | 3 |
| 3 | SURGICAL INFECTIONS | 3212 | 1% | 1% | 6 |
| 4 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1580 | 3% | 0% | 13 |
| 5 | OBESITY SURGERY | 1562 | 2% | 0% | 10 |
| 6 | EJHP PRACTICE | 1391 | 0% | 1% | 2 |
| 7 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 1344 | 0% | 1% | 2 |
| 8 | JOURNAL OF PERIANESTHESIA NURSING | 1009 | 0% | 1% | 2 |
| 9 | DRUG-NUTRIENT INTERACTIONS | 865 | 0% | 1% | 1 |
| 10 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 840 | 2% | 0% | 10 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | WURTZ, R , ITOKAZU, G , RODVOLD, K , (1997) ANTIMICROBIAL DOSING IN OBESE PATIENTS.CLINICAL INFECTIOUS DISEASES. VOL. 25. ISSUE 1. P. 112-118 | 34 | 57% | 63 |
| 2 | HUNTER, RJ , NAVO, MA , THAKER, PH , BODURKA, DC , WOLF, JK , SMITH, JA , (2009) DOSING CHEMOTHERAPY IN OBESE PATIENTS: ACTUAL VERSUS ASSIGNED BODY SURFACE AREA (BSA).CANCER TREATMENT REVIEWS. VOL. 35. ISSUE 1. P. 69-78 | 24 | 52% | 41 |
| 3 | HANLEY, MJ , ABERNETHY, DR , GREENBLATT, DJ , (2010) EFFECT OF OBESITY ON THE PHARMACOKINETICS OF DRUGS IN HUMANS.CLINICAL PHARMACOKINETICS. VOL. 49. ISSUE 2. P. 71-87 | 27 | 34% | 180 |
| 4 | BLOUIN, RA , WARREN, GW , (1999) PHARMACOKINETIC CONSIDERATIONS IN OBESITY.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 88. ISSUE 1. P. 1-7 | 34 | 48% | 85 |
| 5 | BRILL, MJE , DIEPSTRATEN, J , VAN RONGEN, A , VAN KRALINGEN, S , VAN DEN ANKER, JN , KNIBBE, CAJ , (2012) IMPACT OF OBESITY ON DRUG METABOLISM AND ELIMINATION IN ADULTS AND CHILDREN.CLINICAL PHARMACOKINETICS. VOL. 51. ISSUE 5. P. 277 -304 | 44 | 23% | 56 |
| 6 | JOHNSON, PN , MILLER, JL , HAGEMANN, TM , MOFFETT, BS , (2016) ASSESSMENT OF INPATIENT ADMISSIONS AND TOP 25 MEDICATIONS FOR OBESE PEDIATRIC PATIENTS AT TWO ACADEMIC HOSPITALS.AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. VOL. 73. ISSUE 16. P. 1243 -1249 | 19 | 59% | 0 |
| 7 | JANSON, B , THURSKY, K , (2012) DOSING OF ANTIBIOTICS IN OBESITY.CURRENT OPINION IN INFECTIOUS DISEASES. VOL. 25. ISSUE 6. P. 634-649 | 35 | 30% | 36 |
| 8 | GRIGGS, JJ , MANGU, PB , ANDERSON, H , BALABAN, EP , DIGNAM, JJ , HRYNIUK, WM , MORRISON, VA , PINI, TM , RUNOWICZ, CD , ROSNER, GL , ET AL (2012) APPROPRIATE CHEMOTHERAPY DOSING FOR OBESE ADULT PATIENTS WITH CANCER: AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 30. ISSUE 13. P. 1553-1561 | 28 | 26% | 143 |
| 9 | PERIC, KM , REEVES, DJ , (2015) TOLERABILITY OF INDUCTION CHEMOTHERAPY DOSING PRACTICES IN ACUTE MYELOID LEUKEMIA PATIENTS.LEUKEMIA RESEARCH. VOL. 39. ISSUE 2. P. 173 -176 | 13 | 76% | 1 |
| 10 | HARRINGTON, L , LEIKER, C , (2007) DOSING OF EMERGENCY CARDIOVASCULAR MEDICATIONS IN OBESE PATIENTS.BARIATRIC NURSING AND SURGICAL PATIENT CARE. VOL. 2. ISSUE 2. P. 131 -139 | 12 | 100% | 0 |
Classes with closest relation at Level 1 |